Abbvie Stock Price Analysis – A Post-Humira Dip, New Drug Hopes, And Election Buzz – Is Now The Time To Buy?
With the loss of Humira’s exclusivity and a recent dip in stock value, many are questioning the future trajectory of AbbVie stock.
Financial Markets Report For Thursday, Nov 14
In this video, Ira Epstein reviews the activity in the Financial Markets after the day that just ended, Thursday, November 14.